Iranian F-14 fleet attacked at a base in central Iran believed to host all the remaining F-14s in Iranian service. Early in ...

Trinamool Congress Rajya Sabha MP Saket Gokhale has launched an explosive attack on Chief Election Commissioner (CEC) Gyanesh ...

President Donald Trump vowed to avenge fallen US servicemembers amid the war with Iran as Israel expanded the conflict with more strikes in Tehran and against Hezbollah in Lebanon on Monday.

Foreign Secretary Yvette Cooper, visiting Kyiv on the fourth anniversary of Vladimir Putin’s invasion of Ukraine, said the UK had “taken decisive action to disrupt the critical financing, military ...

Future Directions for Western Armenian", organized by the USC Dornsife Institute of Armenian Studies with the support of the Calouste Gulbenkian Foundation, brought together scholars, educators, ...

As the government prepares to change the law to strengthen protection for sensitive sites, the industry is gearing up for a boom in the anti-drone market.

Iran is pushing back against U.S. President Donald Trump’s pressure tactics ahead of critical talks in Geneva over Tehran’s nuclear program, alternating between calling his remarks lies to saying nego ...

Think AI-powered tools like Gemini and ChatGPT are only good with text-based input? Think again. They’ve now gotten significantly better at understanding and reacting to human speech − and the ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced that the European ...

Books & the Arts / Claire Baglin’s bracing On the Clock gives its readers a close look at work behind the fry station, and in the process asks what experiences are missing from mainstream letters.

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported financial results for the fourth quarter and full year ...